메뉴 건너뛰기




Volumn 25, Issue 12 II, 2005, Pages

Infection site concentrations: Their therapeutic importance and the macrolide and macrolide-like class of antibiotics

Author keywords

Infection site concentration; Macrolide; Population modeling

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; ERYTHROMYCIN; GATIFLOXACIN; KETOLIDE; MACROLIDE; RADIOISOTOPE; RIFAMPICIN; TELITHROMYCIN;

EID: 29044441066     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.12part2.150S     Document Type: Conference Paper
Times cited : (51)

References (32)
  • 1
    • 0031952586 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
    • Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-12.
    • (1998) Clin Infect Dis , vol.26 , pp. 1-12
    • Craig, W.A.1
  • 2
    • 2142760947 scopus 로고    scopus 로고
    • Antimicrobial pharmacodynamics: Interactions of bug and drug
    • Drusano GL. Antimicrobial pharmacodynamics: interactions of 'bug and drug.' Natl Rev Microbiol 2004;2:289-300.
    • (2004) Natl Rev Microbiol , vol.2 , pp. 289-300
    • Drusano, G.L.1
  • 4
    • 0032515386 scopus 로고    scopus 로고
    • Pharmacodynamics of levofloxacin: A new paradigm for early clinical trials
    • Preston SL, Drusano GL, Berman AL, et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 1998;279:125-9.
    • (1998) JAMA , vol.279 , pp. 125-129
    • Preston, S.L.1    Drusano, G.L.2    Berman, A.L.3
  • 5
    • 2442549489 scopus 로고    scopus 로고
    • The relationship between fluoroquinolone area under the curve: Minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
    • Drusano GL, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J. The relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 2004;189:1590-7.
    • (2004) J Infect Dis , vol.189 , pp. 1590-1597
    • Drusano, G.L.1    Preston, S.L.2    Fowler, C.3    Corrado, M.4    Weisinger, B.5    Kahn, J.6
  • 6
    • 0034812780 scopus 로고    scopus 로고
    • Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
    • Ambrose PG, Grasela DM, Grasela TH, Passarell J, Mayer HB, Pierce PF. Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother 2001;45:2793-7.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 2793-2797
    • Ambrose, P.G.1    Grasela, D.M.2    Grasela, T.H.3    Passarell, J.4    Mayer, H.B.5    Pierce, P.F.6
  • 7
    • 19544366269 scopus 로고    scopus 로고
    • Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
    • Bosnar M, Kelneric Z, Munic V, Erakovic V, Parnham MJ. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 2005;49:2372-7.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 2372-2377
    • Bosnar, M.1    Kelneric, Z.2    Munic, V.3    Erakovic, V.4    Parnham, M.J.5
  • 8
    • 0026454434 scopus 로고
    • In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes
    • Frank MO, Sullivan GW, Carper HT, Mandell GL. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob Agents Chemother 1992;36:2584-8.
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 2584-2588
    • Frank, M.O.1    Sullivan, G.W.2    Carper, H.T.3    Mandell, G.L.4
  • 9
    • 0035016761 scopus 로고    scopus 로고
    • Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils
    • Mandell GL, Coleman E. Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2001;45:1794-8.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 1794-1798
    • Mandell, G.L.1    Coleman, E.2
  • 10
    • 0024522884 scopus 로고
    • In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: Possible mechanism of delivery and release at sites of infection
    • Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
    • (1989) Antimicrob Agents Chemother , vol.33 , pp. 277-282
    • Gladue, R.P.1    Bright, G.M.2    Isaacson, R.E.3    Newborg, M.F.4
  • 12
    • 0026054990 scopus 로고
    • Azithromycin concentrations in sinus fluid and mucosa after oral administration
    • Karma P, Pukander J, Penttila M. Azithromycin concentrations in sinus fluid and mucosa after oral administration. Eur J Clin Microbiol Infect Dis 1991;10:856-9.
    • (1991) Eur J Clin Microbiol Infect Dis , vol.10 , pp. 856-859
    • Karma, P.1    Pukander, J.2    Penttila, M.3
  • 13
    • 0041767551 scopus 로고    scopus 로고
    • Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults
    • Rodvold KA, Danziger LH, Gotfried MH. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Antimicrob Agents Chemother 2003;47:2450-7.
    • (2003) Antimicrob Agents Chemother , vol.47 , pp. 2450-2457
    • Rodvold, K.A.1    Danziger, L.H.2    Gotfried, M.H.3
  • 14
    • 0030956116 scopus 로고    scopus 로고
    • Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers
    • Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother 1997;41:1399-402.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 1399-1402
    • Rodvold, K.A.1    Gotfried, M.H.2    Danziger, L.H.3    Servi, R.J.4
  • 17
    • 2942627414 scopus 로고    scopus 로고
    • Use of pharmacodynamic endpoints in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis
    • Ambrose PG, Anon JB, Owen JS, et al. Use of pharmacodynamic endpoints in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis. Clin Infect Dis 2004;38:1513-20.
    • (2004) Clin Infect Dis , vol.38 , pp. 1513-1520
    • Ambrose, P.G.1    Anon, J.B.2    Owen, J.S.3
  • 18
    • 0021889786 scopus 로고
    • Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics
    • Fleishaker JC, McNamara PJ. Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics. Antimicrob Agents Chemother 1985;28:369-74.
    • (1985) Antimicrob Agents Chemother , vol.28 , pp. 369-374
    • Fleishaker, J.C.1    McNamara, P.J.2
  • 20
    • 0027395804 scopus 로고
    • Single-dose intramuscular ceftriaxone for acute otitis media in children
    • Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. Pediatrics 1993;91:23-30.
    • (1993) Pediatrics , vol.91 , pp. 23-30
    • Green, S.M.1    Rothrock, S.G.2
  • 21
    • 0031003965 scopus 로고    scopus 로고
    • Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston otitis media study group
    • Barnett ED, Teele DW, Klein JO, Cabral HJ, Kharasch SJ. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston otitis media study group. Pediatrics 1997;99:23-8.
    • (1997) Pediatrics , vol.99 , pp. 23-28
    • Barnett, E.D.1    Teele, D.W.2    Klein, J.O.3    Cabral, H.J.4    Kharasch, S.J.5
  • 22
    • 0033023789 scopus 로고    scopus 로고
    • One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: Clinical efficacy and change in nasopharyngeal flora
    • Cohen R, Navel M, Grunberg J, et al. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J 1999;18:403-9.
    • (1999) Pediatr Infect Dis J , vol.18 , pp. 403-409
    • Cohen, R.1    Navel, M.2    Grunberg, J.3
  • 23
    • 1842732534 scopus 로고    scopus 로고
    • Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children
    • Wang CY, Lu CY, Hsieh YC, Lee CY, Huang LM. Intramuscular ceftriaxone in comparison with oral amoxicillin-clavulanate for the treatment of acute otitis media in infants and children. J Microbiol Immunol Infect 2004;37:57-62.
    • (2004) J Microbiol Immunol Infect , vol.37 , pp. 57-62
    • Wang, C.Y.1    Lu, C.Y.2    Hsieh, Y.C.3    Lee, C.Y.4    Huang, L.M.5
  • 24
    • 29044441713 scopus 로고    scopus 로고
    • Explaining the poor bacteriological eradication rate of single-dose ceftriaxone in Group a streptococcal tonsillopharyngitis: A reverse engineering solution using pharmacodynamic modeling
    • Blumer JL, Reed MD, Kaplan EL, Drusano GL. Explaining the poor bacteriological eradication rate of single-dose ceftriaxone in Group A streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling. Pediatrics 2005;116:927-32.
    • (2005) Pediatrics , vol.116 , pp. 927-932
    • Blumer, J.L.1    Reed, M.D.2    Kaplan, E.L.3    Drusano, G.L.4
  • 26
    • 0036720521 scopus 로고    scopus 로고
    • Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae
    • Lonks JR, Garau J, Gomez L, et al. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;35:556-64.
    • (2002) Clin Infect Dis , vol.35 , pp. 556-564
    • Lonks, J.R.1    Garau, J.2    Gomez, L.3
  • 28
    • 0036975207 scopus 로고    scopus 로고
    • In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin
    • Novelli A, Fallani S, Cassetta MI, Arrigucci S, Mazzel T. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. J Chemother 2002;14:584-90.
    • (2002) J Chemother , vol.14 , pp. 584-590
    • Novelli, A.1    Fallani, S.2    Cassetta, M.I.3    Arrigucci, S.4    Mazzel, T.5
  • 29
    • 0036235528 scopus 로고    scopus 로고
    • Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia
    • Tessier PR, Kim MK, Zhou W, et al. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia. Antimicrob Agents Chemother 2002;46:1425-34.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1425-1434
    • Tessier, P.R.1    Kim, M.K.2    Zhou, W.3
  • 30
    • 11244342348 scopus 로고    scopus 로고
    • Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model
    • Tessier PR, Mattoes HM, Dandekar PK, Nightingale CH, Nicolau DP. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model. Antimicrob Agents Chemother 2005;49:188-94.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 188-194
    • Tessier, P.R.1    Mattoes, H.M.2    Dandekar, P.K.3    Nightingale, C.H.4    Nicolau, D.P.5
  • 31
    • 19544384399 scopus 로고    scopus 로고
    • Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model
    • Dandekar PK, Williams P, Tessier PR, Farrell DJ, Nightingale CH, Nicolau DP. Assessment of the efficacy of telithromycin simulating human exposures against S. pneumoniae with ribosomal mutations in a murine pneumonia model. Int J Antimicrob Agents 2005;25:530-4.
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 530-534
    • Dandekar, P.K.1    Williams, P.2    Tessier, P.R.3    Farrell, D.J.4    Nightingale, C.H.5    Nicolau, D.P.6
  • 32
    • 18244382544 scopus 로고    scopus 로고
    • Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary
    • Zhanel GG, Johanson C, Laing N, Hisananga T, Wierzbowski A, Hoban DJ. Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary. Antimicrob Agents Chemother 2005;49:1943-8.
    • (2005) Antimicrob Agents Chemother , vol.49 , pp. 1943-1948
    • Zhanel, G.G.1    Johanson, C.2    Laing, N.3    Hisananga, T.4    Wierzbowski, A.5    Hoban, D.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.